Bisphosphonates: Mechanisms of action and clinical use in osteoporosis - An update

被引：53
|
作者：
Fleisch, H
机构：
来源：
HORMONE AND METABOLIC RESEARCH | 1997年 / 29卷 / 03期
关键词：
bisphosphonates; osteoporosis; bone;
D O I：
10.1055/s-2007-979008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Bisphosphonates are a new class of compounds with the ability to decrease bone resorption. Their mode of action appears to be complex, involving both a direct effect on the osteoclasts and an indirect one through osteoblasts. They are currently the drugs of choice in humans for Paget's disease and tumor bone disease, and are most useful in various types of osteoporosis. In view of their low toxicity, they are a most valuable addition to our therapeutic possibilities in the treatment of bone diseases.
引用
收藏
页码：145 / 150
页数：6
相关论文
共 50 条
  • [1] Bisphosphonates - An update on mechanisms of action and how these relate to clinical efficacy
    Russell, R. Graham G.
    Xia, Zhidao
    Dunford, James E.
    Oppermann, Udo
    Kwaasi, Aaron
    Hulley, Philippa A.
    Kavanagh, Kathryn L.
    Triffitt, James T.
    Lundy, Mark W.
    Phipps, Roger J.
    Barnett, Bobby L.
    Coxon, Fraser P.
    Rogers, Michael J.
    Watts, Nelson B.
    Ebetino, Frank H.
    [J]. SKELETAL BIOLOGY AND MEDICINE, PT B: DISEASE MECHANISMS AND THERAPEUTIC CHALLENGES, 2007, 1117 : 209 - 257
  • [2] Intravenous Immunoglobulin: An Update on the Clinical Use and Mechanisms of Action
    VIR-SINGH NEGI
    SRIRAMULU ELLURU
    SOPHIE SIBÉRIL
    STÉPHANIE GRAFF-DUBOIS
    LUC MOUTHON
    MICHEL D. KAZATCHKINE
    SÉBASTIEN LACROIX-DESMAZES
    JAGADEESH BAYRY
    SRINI V. KAVERI
    [J]. Journal of Clinical Immunology, 2007, 27 : 233 - 245
  • [3] Intravenous immunoglobulin:: An update on the clinical use and mechanisms of action
    Negi, Vir-Singh
    Elluru, Sriramulu
    Siberil, Sophie
    Graff-Dubois, Stephanie
    Mouthon, Luc
    Kazatchkine, Michel D.
    Lacroix-Desmazes, Sebastien
    Bayry, Jagadeesh
    Kaveri, Srini V.
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2007, 27 (03) : 233 - 245
  • [4] Bisphosphonates: Pharmacology, mechanisms of action and clinical uses
    Russell, RGG
    Croucher, PI
    Rogers, MJ
    [J]. OSTEOPOROSIS INTERNATIONAL, 1999, 9 (Suppl 2) : 66 - 80
  • [5] Bisphosphonates: Pharmacology, Mechanisms of Action and Clinical Uses
    R. G. G. Russell
    P. I. Croucher
    M. J. Rogers
    [J]. Osteoporosis International, 1999, 9 : S66 - S80
  • [6] Bisphosphonates for the treatment of postmenopausal osteoporosis: An update
    Cranney A.
    Adachi J.D.
    [J]. Clinical Reviews in Bone and Mineral Metabolism, 2007, 5 (3): : 145 - 152
  • [7] Update on the use of bisphosphonates in the management of postmenopausal osteoporosis by obstetricians-gynecologists
    Sunyecz, John A.
    Derman, Richard
    [J]. OBSTETRICAL & GYNECOLOGICAL SURVEY, 2007, 62 (06) : 407 - 416
  • [8] THE USE OF BISPHOSPHONATES IN OSTEOPOROSIS
    FLEISCH, H
    [J]. BRITISH JOURNAL OF CLINICAL PRACTICE, 1994, 48 (06): : 323 - 326
  • [9] BISPHOSPHONATES FOR OSTEOPOROSIS More on the use of bisphosphonates in the prevention and treatment of osteoporosis
    Minisola, Salvatore
    Cipriani, Cristiana
    Scillitani, Alfredo
    Pepe, Jessica
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
  • [10] Mechanisms of action of bisphosphonates
    Breuil, V
    [J]. REVUE DU RHUMATISME, 1999, 66 (06): : 339 - 343
12345